122 related articles for article (PubMed ID: 38750863)
1. Microcrystalline cellulose from soybean hull as an excipient in solid dosage forms: Preparation, powder characterization, and tableting properties.
Alamdari NE; Aksoy B; Babu RJ; Jiang Z
Int J Biol Macromol; 2024 Jun; 270(Pt 1):132298. PubMed ID: 38750863
[TBL] [Abstract][Full Text] [Related]
2. Utility of Microcrystalline Cellulose for Improving Drug Content Uniformity in Tablet Manufacturing Using Direct Powder Compression.
Nakamura S; Tanaka C; Yuasa H; Sakamoto T
AAPS PharmSciTech; 2019 Mar; 20(4):151. PubMed ID: 30903317
[TBL] [Abstract][Full Text] [Related]
3. Preparation, characterization, and tabletting properties of a new cellulose-based pharmaceutical aid.
Kumar V; de la Luz Reus-Medina M; Yang D
Int J Pharm; 2002 Mar; 235(1-2):129-40. PubMed ID: 11879748
[TBL] [Abstract][Full Text] [Related]
4. Application of Co-processed Excipient as a Novel Method to Compound Orally Disintegrating Tablets.
Liew KB; Hii SH; Chew YL; Ming LC; Uddin AH; Sarker ZI
Int J Pharm Compd; 2022; 26(3):255-263. PubMed ID: 35657749
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of powder and tableting properties of low and high degree of polymerization cellulose I and cellulose II excipients.
de la Luz Reus Medina M; Kumar V
Int J Pharm; 2007 Jun; 337(1-2):202-9. PubMed ID: 17376616
[TBL] [Abstract][Full Text] [Related]
6. Fine grade engineered microcrystalline cellulose excipients for direct compaction: Assessing suitability of different dry coating processes.
Chen L; He Z; Kunnath K; Zheng K; Kim S; Davé RN
Eur J Pharm Sci; 2020 Aug; 151():105408. PubMed ID: 32502519
[TBL] [Abstract][Full Text] [Related]
7. Orally Disintegrating Tablet Manufacture via Direct Powder Compression Using Cellulose Nanofiber as a Functional Additive.
Nakamura S; Fukai T; Sakamoto T
AAPS PharmSciTech; 2021 Dec; 23(1):37. PubMed ID: 34950985
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of tableting and tablet properties of Kollidon SR: the influence of moisture and mixtures with theophylline monohydrate.
Hauschild K; Picker-Freyer KM
Pharm Dev Technol; 2006 Feb; 11(1):125-40. PubMed ID: 16544916
[TBL] [Abstract][Full Text] [Related]
9. An experimental investigation of temperature rise during compaction of pharmaceutical powders.
Krok A; Mirtic A; Reynolds GK; Schiano S; Roberts R; Wu CY
Int J Pharm; 2016 Nov; 513(1-2):97-108. PubMed ID: 27601333
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of non-crystalline cellulose as a novel excipient in solid dose products.
Pawar K; Render D; Rangari V; Lee Y; Babu RJ
Drug Dev Ind Pharm; 2018 Sep; 44(9):1512-1519. PubMed ID: 29734848
[TBL] [Abstract][Full Text] [Related]
11. Studies on the influence of high-shear granulation process on the compressibility of microcrystalline cellulose.
Xiao B; Zhang J; Geng L; Tang X; Wang Y; Yin T; Zhang Y; Gou J; He H
Int J Pharm; 2022 Sep; 625():122075. PubMed ID: 35931395
[TBL] [Abstract][Full Text] [Related]
12. Insight Into a Novel Strategy for the Design of Tablet Formulations Intended for Direct Compression.
Capece M; Huang Z; Davé R
J Pharm Sci; 2017 Jun; 106(6):1608-1617. PubMed ID: 28283431
[TBL] [Abstract][Full Text] [Related]
13. Comparison of traditional and novel tableting excipients: physical and compaction properties.
Hentzschel CM; Sakmann A; Leopold CS
Pharm Dev Technol; 2012; 17(6):649-53. PubMed ID: 21740091
[TBL] [Abstract][Full Text] [Related]
14. Microparticle surface layering through dry coating: impact of moisture content and process parameters on the properties of orally disintegrating tablets.
Alyami H; Koner J; Dahmash EZ; Bowen J; Terry D; Mohammed AR
J Pharm Pharmacol; 2017 Jul; 69(7):807-822. PubMed ID: 27696423
[TBL] [Abstract][Full Text] [Related]
15. Spray-dried cellulose nanofibers as novel tablet excipient.
Kolakovic R; Peltonen L; Laaksonen T; Putkisto K; Laukkanen A; Hirvonen J
AAPS PharmSciTech; 2011 Dec; 12(4):1366-73. PubMed ID: 22005956
[TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of the powder properties and compression behaviour of a new cellulose-based direct compression excipient and Avicel PH-102.
Reus-Medina M; Lanz M; Kumar V; Leuenberger H
J Pharm Pharmacol; 2004 Aug; 56(8):951-6. PubMed ID: 15285837
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of cellulose II powders as a potential multifunctional excipient in tablet formulations.
de la Luz Reus Medina M; Kumar V
Int J Pharm; 2006 Sep; 322(1-2):31-5. PubMed ID: 16828996
[TBL] [Abstract][Full Text] [Related]
18. An update on microcrystalline cellulose in direct compression: Functionality, critical material attributes, and co-processed excipients.
Zhao H; Zhao L; Lin X; Shen L
Carbohydr Polym; 2022 Feb; 278():118968. PubMed ID: 34973783
[TBL] [Abstract][Full Text] [Related]
19. Direct compression of cushion-layered ethyl cellulose-coated extended release pellets into rapidly disintegrating tablets without changes in the release profile.
Hosseini A; Körber M; Bodmeier R
Int J Pharm; 2013 Dec; 457(2):503-9. PubMed ID: 23892153
[TBL] [Abstract][Full Text] [Related]
20. Preparation of rapidly disintegrating tablet using new types of microcrystalline cellulose (PH-M series) and low substituted-hydroxypropylcellulose or spherical sugar granules by direct compression method.
Ishikawa T; Mukai B; Shiraishi S; Utoguchi N; Fujii M; Matsumoto M; Watanabe Y
Chem Pharm Bull (Tokyo); 2001 Feb; 49(2):134-9. PubMed ID: 11217097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
